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Non-Diabetic Renal Disease in Patients with Type-2 Diabetes Mellitus
Sonia Yaqub, Waqar Kashif, Syed Ather Hussain
Section of Nephrology, Department of Medicine, Aga Khan University Hospital, Karachi,
Pakistan
ABSTRACT. Diabetic nephropathy (DN) is the leading cause of end-stage renal disease in diabetics
worldwide, yet most patients with type-2 diabetes mellitus are not formally evaluated with a renal biopsy.
The diagnosis is almost always based on clinical grounds. A wide spectrum of non-diabetic renal disease
(NDRD) is reported to occur in patients with type-2 diabetes. It has been estimated that up to one-third of
all diabetic patients who present with proteinuria are suffering from NDRD. The aim of this analysis was to
evaluate the prevalence and etiology of NDRD in patients with type-2 diabetes. We retrospectively reviewed
the medical records of patients with type-2 diabetes who underwent kidney biopsy on clinical suspicion of
NDRD (absence of diabetic retinopathy and/or neuropathy; short duration of diabetes, i.e. less than five
years) from January 2003 through December 2007 at the Aga Khan University Hospital, Karachi. Based on
the biopsy findings, patients were grouped as Group-I, isolated NDRD; Group-II, NDRD with underlying
DN; and Group-III, isolated DN. Of 68 patients studied, 75% were males and the mean age was 56 years.
The mean duration of diabetes was nine years. Group-I included 34 patients (52%), Group-II included 11
patients (17%) and Group-III included 23 patients (31%). Among the Group-I patients, the mean age was
56 years (41–77 years). The most common NDRDs were acute interstitial nephritis (32%), diffuse proliferative glomerulonephritis (17%); membranous nephropathy (12%) and crescentic glomerulonephritis (12%).
Among Group-II, the mean age was 60 years (46–71 years), and the most common lesion was interstitial
nephritis superimposed on underlying DN (63% cases). Among Group-III, the mean age was 53 years (42–
80 years). The mean proteinuria was 5, 6.3 and 7.3 g/24 h of urine collection in Groups I, II and III, respectively (P = NS). The mean duration of diabetes was 7.3, 11.7 and 10.7 years in Groups I, II and III, respectively. The duration of diabetes was significantly less in Group-I compared with Group-II and Group-III (P =
0.04). Our study suggests that the prevalence of NDRD (either isolated or superimposed on underlying DN)
is high in appropriate clinical settings. Performing renal biopsy in diabetics with no extrarenal end organ
damage other than nephropathy helps to diagnose and treat NDRD. This is the first report from Pakistan
documenting the prevalence of NDRD in patients with type-2 diabetes.
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Introduction
The incidence and prevalence of diabetes
mellitus are on the rise worldwide.1 Nearly 21
million people in the United States (7% of the
population) have diabetes, and about one-third
of those with diabetes are unaware of their condition.2 Worldwide, 171 million people have
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diabetes.2 It is projected that in the US population, the prevalence of diabetes will increase
by 165% between 2000 and 2050, with the
greatest increase being in older individuals
(>75 years) and among African Americans.3
The global burden of diabetes is expected to
double between 2000 and 2030, with the greatest increase in prevalence occurring in the
Middle East, Sub-Saharan Africa and India.2
This is attributed to the progressive demographic transition worldwide with urbanization
along with increased and prolonged exposure
of the ageing population to unhealthy lifestyles,
including a calorie-dense diet and physical inactivity.4
Diabetic nephropathy (DN), one of the complications of diabetes, has been the leading
cause of end-stage renal disease (ESRD) in
developed countries, and has been increasing
rapidly in many developing countries.5,6 According to the United States Renal Dialysis Registry System (USRDS) 2006 Report, DN is
the primary cause of kidney failure in approximately 45% of the patients receiving dialysis
therapy.7 Moreover, 15–23% of the patients
with diabetes are estimated to have advanced
stages (moderate to severe) of chronic kidney
disease.8,9
But, this story is not simple because all renal
diseases that occur in diabetic patients need
not always be DN. It has been estimated that
up to one-third of diabetic patients who present with proteinuria are suffering from nondiabetic renal diseases (NDRD).10-14 The usual
criteria for suspecting NDRD and performing
kidney biopsy in patients with type-1 diabetes
are presence of microscopic hematuria, absence
of diabetic retinopathy, uncharacteristic change
in kidney function or presence of other systemic diseases.15 However, the validity of these
clinical conditions is not well established for
patients with type-2 diabetes. The occurrence
of isolated NDRD or with concurrent DN has
important implications for therapy and prognosis as DN is hard to reverse, but some NDRD
are often treatable and even remittable.
The prevalence of NDRD in patients with type2 diabetes has been variably reported in the
published literature. Studies from India have
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reported the prevalence of NDRD to vary from
12% to 72.5%.16 The prevalence and nature of
NDRD in patients with type-2 diabetes is not
documented in Pakistan.
The aim of this study is to assess the prevalence and to study the etiology of NDRD
and correlate it with clinical parameters such
as duration of diabetes, amount of proteinuria
and microscopic hematuria at a tertiary care
hospital in Pakistan.
Materials and Methods
We retrospectively reviewed the medical records of patients who underwent kidney biopsy
from January 2003 through December 2007 at
our institute, The Aga Khan University Hospital. Of 273 patients who had undergone renal
biopsy, 68 had type-2 diabetes and were biopsied on clinical suspicion of NDRD.
The indications for renal biopsy in the diabetic patients included the following:
• Nephrotic range proteinuria or renal impairment (serum creatinine ≥1.5 mg/dL) in
the absence of diabetic retinopathy
• Nephrotic range proteinuria or renal impairment (serum creatinine ≥1.5 mg/dL)
with duration of diabetes shorter than five
years
• Unexplained microscopic hematuria, defined
as more than three red blood cells per high
power field in a centrifuged urine sample
• Unexplained acute kidney injury, defined
as unexplained rise in serum creatinine
≥0.5 mg/dL in a patient with previously
normal kidney function
• Rapidly declining renal function in patients
with previously stable renal function
• Sudden onset of nephrotic range proteinuria with normal kidney function.
Patients with ESRD were excluded. The
biopsy material was processed for light microscopy and immunofluorescence. DN was diagnosed by an experienced renal pathologist by
the presence of mesangial expansion and diffuse inter-capillary glomerulosclerosis, with or
without the nodular Kimmelstiel–Wilson formation, basement membrane thickening, fibrin
caps or capsular drops.
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Based on the biopsy findings, the patients
were categorized as follows:
Group-I: Isolated NDRD
Group-II: NDRD superimposed on underlying
DN
Group-III: Isolated DN
Clinical details including age, gender, duration of diabetes, presence or absence of hypertension, presence or absence of diabetic retinopathy and indication for biopsy were recorded
from the case records. The laboratory profile
noted included blood urea nitrogen (BUN),
serum creatinine, urinalysis and degree of proteinuria either by 24-h urine collection or by
spot urine protein to creatinine ratio.
Definitions
The duration of diabetes was defined as the
period between the age at onset and age at performing renal biopsy. Hypertension was defined
as blood pressure more than 140/90 mmHg
with or without antihypertensives. Diabetic
retinopathy was diagnosed on fundoscopy by
an ophthalmologist; diagnostic findings included presence of background retinopathy
(microaneurysms, hemorrhages, soft exudates,
hard exudates) with or without proliferative
changes.
Statistical Analysis
Correlation of histological findings with clinical and biochemical parameters was carried
out. Collected data were analyzed using SPSS
for windows version 15. Data are expressed as
mean ± SD. Differences between groups were
assessed by using the univariate chi-square test
for categorical variables, unpaired t-test or
ANOVA for continuous variables where appropriate; P <0.05 was considered statistically
significant.
Results
A total of 68 patients with type-2 diabetes
underwent renal biopsy during the study period. Thirty-four patients (52%) belonged to
Group-I (isolated NDRD), 11 (17%) to Group-II
(NDRD with underlying DN) and 23 (31%) to

Figure 1. Group frequencies among the study
patients.

Group-III (isolated DN) (Figure 1). Clinical and
laboratory parameters in the three groups are
shown in Table 1. Males outnumbered females
in all the groups. The duration of diabetes was
significantly less in Group-I than in Group-II
and Group-III (P = 0.04). The prevalence of
hypertension was similar in all three groups.
Level of proteinuria was higher in Group-II
and Group-III when compared with Group-I,
but the difference was not statistically significant. The serum creatinine levels were significantly higher in Group-II and Group-III (P
<0.0001). The incidence of microscopic hematuria was not different among the three groups.
Indications for renal biopsy included rapidly
declining renal function in 31 patients (45.5%),
absence of diabetic retinopathy in 12 patients
(17.6%), unexplained acute kidney injury in 12
patients (17.6%) and duration of diabetes
mellitus less than five years in nine patients
(13.2%), and miscellaneous in eight others
(Table 2).
The histological lesions identified in patients
in Group-I and Group-II are presented in Table
3. Among Group-I patients, the most common
NDRD were acute interstitial nephritis (AIN)
(32%), diffuse proliferative glomerulonephritis
(20.5%); membranous nephropathy (12%) and
crescentic glomerulonephritis (12%), while
Group-II predominantly comprised AIN (63%).
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Table 1. Clinical and laboratory parameters in the different groups of patients studied.
Group-I
Group-II
Total
Parameters
n = 34
n = 11
n = 68
(NDRD)
(NDRD + DN)
Age at biopsy (years)
56 ± 8
56 ± 9
60 ± 8
Gender (M/F)
51/17
20/14
10/1
Duration of diabetes (years)
9 (SD 6.8)
7.3 (SD 7)
11.7 (SD 10)
Hypertension (%)
89.7
75.7
91.6
Mean serum creatinine
4.5 (SD 2.56)
3.45 (SD 1.9)
5.1 (SD 2.1)
(mg/dL)
Proteinuria (g/24 h)
5 (0.3–20)
6.3 (2–10)
Microhematuria (%)
51.4
60.6
41.6
NDRD: non-diabetic renal disease, DN: diabetic nephropathy

Discussion
DN is one of the most frequent and clinically
important complications of diabetes mellitus.
It affects approximately 40% of the patients
who have had diabetes for more than 20 years
and has become the leading cause of ESRD
worldwide.5,6,17
The diagnosis of DN is almost always based
on clinical grounds and is supported by a long
history of diabetes, evidence of target organ
damage and proteinuria preceding azotemia.
However, DN is not the only renal disease in
diabetes. Many NDRD have been uncovered
by renal biopsy. It has been shown that renal
disease in patients suffering from type-1 diabetes for more than 10 years, especially in the
presence of diabetic retinopathy or neuropathy,
is usually the result of DN, and it has been
proven histologically in >95% of the patients.
But, this is not the case in patients with type-2

Group-III
n = 23
(DN)
53 ± 9
21/2
10.7 (SD 10)
100

P-value
NS
0.04
NS

5.4 (SD 3)

<0.0001

7.3 (1–13)
34.7

NS
NS

diabetes.18-20 Kidney biopsies from patients
with type-2 diabetes, with renal disease or proteinuria, show that they comprise a more heterogeneous group of renal lesions other than
DN.10-13,16,21-28
Different predicting factors have been identified in diabetic patients found to have NDRD,
including late onset of diabetes, absence of
neuropathy/retinopathy, abrupt onset or progression of renal disease (massive proteinuria or
renal insufficiency) and presence of microscopic hematuria.27,29-31
Among patients with type-2 diabetes who had
renal biopsy, the prevalence of NDRD varies
widely in the published literature, from 12% to
79%, depending on the selection criteria and
the population being studied.10-13,16,21-28,32-34 In
our study, all patients had type-2 diabetes, and
69% of the patients had NDRD (either isolated
or superimposed on underlying DN).
We found a predominance of males in all three

Table 2. Indications for kidney biopsy in the study patients.
Total
Group-I
Indications
(n = 68)
(Isolated NDRD)
n (%)
(n = 34) n (%)
Rapidly declining renal function in
31 (45.5)
10 (30.3)
patients with previously stable renal
function
Heavy proteinuria or renal impairment
12 (17.6)
5 (15.1)
in the absence of diabetic retinopathy
Unexplained acute renal failure
12 (17.6)
10 (30.3)
Heavy proteinuria or renal impairment
9 (13.2)
5 (15.1)
with duration of diabetes mellitus less
than five years
Unexplained microscopic hematuria
3 (4.4)
3 (9.0)
Heavy proteinuria
1 (1.4)
Nil
NDRD: non-diabetic renal disease, DN: diabetic nephropathy

Group-II
(NDRD + DN)
(n = 11) n (%)

Group-III
(Isolated DN) (n
= 23) n (%)

8 (66.6)

13 (56.2)

2 (16.6)

5 (21.7)

Nil

2 (8.6)

2 (16.6)

2 (8.6)

Nil
Nil

Nil
1 (4.3)
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Table 3. Histological diagnosis in patients in Group-I and Group-II.
Histology
Group-I (n = 34)
(Isolated NDRD)
n (%)
Acute interstitial nephritis
11 (32.3)
Diffuse proliferative glomerulonephritis
7 (20.5)
(post-infectious)
Membranous nephropathy
4 (11.7)
Crescentic glomerulonephritis
4 (11.7)
Minimal change disease
2 (5.8)
Focal and segmental glomerulosclerosis
2 (5.8)
IgA nephropathy
2 (5.8)
Amyloidosis
1 (2.9)
Lupus nephritis
1 (2.9)
Membranoproliferative glomerulonephritis
End-stage renal disease
NDRD: non-diabetic renal disease, DN: diabetic nephropathy

three groups. It was found that patients with
isolated DN were younger than patients with
NDRD (either isolated or mixed disease). The
duration of diabetes was significantly less in
the isolated NDRD group compared with the
other groups. Thus, shorter duration of diabetes and older age could be risk factors for
NDRD. Lee et al also concluded that a shorter
duration of diabetes was significantly associated with NDRD.23 Similar results were reported by Wong, Tone and Huang et al.14,28,35
Soni et al from India also reported that a short
duration of diabetes was a predictor of
NDRD.16 However, Bertani et al and Mak et al
found no significant difference in the duration
of diabetes among the different groups.24,36
The prevalence of hypertension was similar in
all three groups in our study, which is consistent with the findings reported by Soni and
Matias et al.16,37
We found that patients with isolated DN as
well as those with mixed disease tended to
have higher levels of proteinuria compared
with the group with isolated NDRD; the difference did not achieve statistical significance.
Lin et al also reported lower proteinuria in
patients with NDRD thus making it a significant factor indicative of renal biopsy.32 Mak
et al found that patients with isolated DN had a
higher degree of proteinuria when compared
with those with NDRD.24
In this study, the serum creatinine levels were

Group-II (n = 11)
(NDRD superimposed on
underlying DN) n (%)
7 (63.6)
1 (9)
3 (27.2)

significantly higher in patients with DN (isolated as well as with superimposed disease)
compared with those with NDRD (P <0.0001).
Similar results were reported by Matias et al
while Soni et al showed that the degree of azotemia was higher in patients having superimposed NDRD.16,37 Taft et al reported that in
patients with DN, co-existing renal disease was
found to be associated with a significantly
higher creatinine level, independent of the severity of DN.38 Mak and Lin et al found that
patients with both isolated DN and NDRD did
not have any difference in serum creatinine
levels.24,32
The presence of microscopic hematuria has
been suggested by different authors to be one
of the atypical features indicating presence of
NDRD. Mak and Matias et al found a strong
correlation between NDRD and microscopic
hematuria.24,37 On the contrary, Serra et al reported that DN was most commonly found in
diabetic patients manifesting microscopic hematuria.15 In our study, there was no difference
in the prevalence of microscopic hematuria
among the three groups. Other authors also
found that the frequency of microscopic hematuria was similar in those with DN and NDRD
(isolated and superimposed).16,32 A Japanese
study by Tone showed that microscopic hematuria had lower sensitivity and specificity for
the prediction of NDRD compared with the
other parameters, suggesting that microscopic
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hematuria is not a good predictor of NDRD.28
Absence of diabetic retinopathy is said to be
one of the important predictors of NDRD. In
people with type-1 diabetes, the association is
stronger than in those with type-2 diabetes.
This correlation has been reported by Lee et al,
who showed that absence of retinopathy was
one of the significant factors that predicts
NDRD.23 Tone et al reported that absence of
retinopathy showed the highest sensitivity
(87%) and specificity (93%) for the prediction
of NDRD.28 Similar findings have been reported by others.16,26,37 Wong et al showed that
absence of retinopathy with hematuria and/or
proteinuria ≥2 g/day constitutes the most sensitive marker for NDRD and is thus a strong
indication for biopsy.14 However, a few studies
have demonstrated lack of correlation between
NDRD and presence of retinopathy.24,32
Histologically, NDRD comprised a heterogeneous group in our study. In Group-I patients
(isolated NDRD), the most common NDRD
was AIN, followed by diffuse proliferative
glomerulonephritis, membranous nephropathy
and crescentic glomerulonephritis (Table 3).
Among Group-II patients also (mixed disorder
DN plus NDRD), AIN was the most common
lesion. Thus, AIN was the most frequent
NDRD seen in 40% of the patients overall
(both Group-I and Group-II). In a study from
Taiwan, AIN was the most prevalent NDRD
(46.5%), followed by membranous nephropathy
and IgA nephropathy.32 An Indian study also
found AIN to be the most common NDRD,
found in 18.1% of the patients with mixed
renal disease (NDRD superimposed on DN),
while membranous nephropathy (19.2%) was
the most frequent diagnosis in patients with
isolated NDRD.16 IgA nephropathy is reported
to be the most frequent type of NDRD in the
Chinese, Korean and Japanese population with
diabetes.23,24,28,40 It is important to keep in mind
that interstitial inflammatory cell infiltration is
often prominent in advanced diabetic glomerulosclerosis. Thus, it is hard to know whether
this is secondary to DN or superimposed with
AIN, particularly when there is no prominent
eosinophil interstitial infiltration. These tubulointerstitial changes in DN are said to be related
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to the renal microvascular alterations characteristic of long-term diabetes, and it is now generally held that they are due to chronic ischemia.41
The pathogenesis of NDRD in patients with
diabetes is not well understood. Whether there
are common etiologic factors in relation to
diabetes or it is merely a coincidence is not
clear. Some authors have suggested that the
predisposition of DN to superimposed nephritis could be attributed to enhanced exposure
of antigenic cellular components, triggering
immune responses.40 Others, however, found
no difference in the prevalence of NDRD between patients with and without diabetes and
that the co-existence of a different glomerulonephritis in the diabetic kidney may be merely
coincidental.11,14,42 The renal outcome in diabetic patients with NDRD varies and depends on
the specific type of non-diabetic renal lesion.
We conclude that the prevalence of NDRD,
either isolated or superimposed on underlying
DN, is high in diabetics with proteinuria. It is
recommended that nephrologists maintain a
high index of suspicion for performing renal
biopsy in diabetic patients. Early diagnosis of
NDRD helps in instituting appropriate therapy,
which in turn could aid in prolonging renal
survival in this patient population.
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